Prevalence and burden of symptomatic uterine leiomyomata among women in Imo State, South-Eastern Nigeri
DOI:
https://doi.org/10.30574/gscbps.2021.16.2.0218Keywords:
Prevalence, Leiomyomata, Ultrasonography, Burden, Frequency, FibroidsAbstract
Despite high rates of Uterine Leiomyomata (UL) diagnoses found in black women, there is paucity in research. Therefore, this study aimed at estimating the prevalence and burden of symptomatic UL among women in Imo State, Nigeria. The study is a descriptive cross-sectional hospital-based study that was carried out in Radiology, Obstetrics and Gynaecology departments of three hospitals and two diagnostic Centres covering the three senatorial zones in Imo State. The research was based on a convenience sampling of 2965 women within the age group of 16 to 49 that reside in the 3 senatorial zones referred for an ultrasound scan and who met the selection criteria within the period of study. Eligible and consented women responded to the questionnaire and underwent a transabdominal ultrasound. The data were analysed with the statistical program PASW 18 and p values < 0.05 were taken to be statistically significant. Weighted means and percentages were reported and prevalence across the senatorial zones was examined. Symptom burden among women with and without uterine fibroids was compared using weighted logistic regressions. Of 2965 respondents who met study inclusion criteria, a total of 652(22.0%) were diagnosed having UL while 2313 (78.0%) do not have the disease. Hence the overall prevalence of UL at clinics/Diagnostic centres in Imo State was 22%. Uterine fibroids impose a heavy burden on women aged 16–49 years in Imo State. It represents an important gynecologic pathology in women due to its relatively high prevalence and its significant impact on patient’s quality of life.
Metrics
References
Marsh EE, Ekpo GE, Cardozo ER, Brocks M, Dune T, Cohen LS. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18−30 years old): a pilot study. Fertility and Sterility. 2013; 99(7): 1951−7.
Munusamy MM, Sheelaa WG, Lakshmi VP. Clinical presentation and prevalence of uterine fibroids: a 3-year study in 3-decade rural South Indian women. International Journal of Reproduction, Contraception, Obstetrics and Gynaecology. 2017; 6: 5596-601.
Mas A, Tarazona M, Dasi Carrasco J, Estaca G, Cristobal I, Monleon J. Updated approaches for management of uterine fibroids. International Journal of Womens Health. 2013; 9: 607–1718.
Atombosoba A, Ekine Lucky, O Lawani, Chukwuemeka A. Iyoke, Israel Jeremiah, and Isa A. Ibrahim. “Review of the Clinical Presentation of Uterine Fibroid and the Effect of Therapeutic Intervention on Fertility, American Journal of Clinical Medicine Research. 2015; 3(1): 9-13.
Cochran WG. Sampling technique. New York: John willey& Sons. 1977.
Ozumba BC, Nzegwu MA, Nyikam AA. Histological patterns of Gynaecological Lesions in Enugu, Nigeria, A five-year review from January1, 2000 to December 31, 2004. Advanced Bioresources. 2011; 2(2): 132-6.
Ukwenya V, Madumezia N, Afolayan O, Alese, Thomas W. Prevalence Of Uterine Fibroid in South- Western Nigerian Population: A sonographic. Journal exp Clinical Anatomy. 2015; 14: 24-9.
William ARW. Uterine fibroids – what’s new? F1000Research, 6 F1000. Faculty Rev). 2017; 2109.
Omokanye LO, Salaudeen GA, Saidu R, Jimoh AAG, Balogun OR. Surgical management of uterine fibroids at the University of Ilorin Teaching Hospital: A 5-year review. Global Res. J. Med. Sci. 2012; 2(2): 018 – 022.
Ezeama CO, Ikechebelu JI, Obiechina NJ, Ezeama NN. Clinical presentation of uterine fibroids in Nnewi, Nigeria: A 5
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.